HCP, Inc. (HCP) Shares Bought by Pacer Advisors Inc.

Pacer Advisors Inc. boosted its stake in shares of HCP, Inc. (NYSE:HCP) by 8.4% during the 2nd quarter, according to its most recent 13F filing with the SEC. The firm owned 11,370 shares of the real estate investment trust’s stock after buying an additional 877 shares during the period. Pacer Advisors Inc.’s holdings in HCP were worth $363,000 as of its most recent filing with the SEC.

A number of other hedge funds also recently made changes to their positions in HCP. State of New Jersey Common Pension Fund D acquired a new stake in HCP during the 1st quarter worth approximately $1,126,000. DekaBank Deutsche Girozentrale raised its holdings in HCP by 73.5% during the 1st quarter. DekaBank Deutsche Girozentrale now owns 34,958 shares of the real estate investment trust’s stock worth $1,126,000 after buying an additional 14,807 shares during the period. US Bancorp DE raised its holdings in HCP by 4.7% during the 1st quarter. US Bancorp DE now owns 42,362 shares of the real estate investment trust’s stock worth $1,325,000 after buying an additional 1,891 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank raised its holdings in HCP by 37.0% during the 1st quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 171,029 shares of the real estate investment trust’s stock worth $5,350,000 after buying an additional 46,161 shares during the period. Finally, Crawford Investment Counsel Inc. raised its holdings in HCP by 10.7% during the 1st quarter. Crawford Investment Counsel Inc. now owns 274,106 shares of the real estate investment trust’s stock worth $8,574,000 after buying an additional 26,603 shares during the period. Hedge funds and other institutional investors own 89.75% of the company’s stock.

ILLEGAL ACTIVITY WARNING: “HCP, Inc. (HCP) Shares Bought by Pacer Advisors Inc.” was first published by Sports Perspectives and is owned by of Sports Perspectives. If you are viewing this piece on another publication, it was stolen and reposted in violation of U.S. and international copyright and trademark laws. The original version of this piece can be viewed at https://sportsperspectives.com/2017/09/11/hcp-inc-hcp-shares-bought-by-pacer-advisors-inc.html.

HCP, Inc. (HCP) opened at 30.21 on Monday. The company has a market capitalization of $14.17 billion, a PE ratio of 20.59 and a beta of 0.38. HCP, Inc. has a 1-year low of $27.61 and a 1-year high of $39.70. The company has a 50 day moving average of $30.03 and a 200 day moving average of $31.13.

HCP (NYSE:HCP) last released its quarterly earnings results on Tuesday, August 1st. The real estate investment trust reported $0.48 EPS for the quarter, beating analysts’ consensus estimates of $0.47 by $0.01. The business had revenue of $458.90 million during the quarter, compared to analyst estimates of $456.29 million. HCP had a return on equity of 9.96% and a net margin of 32.16%. HCP’s quarterly revenue was down 14.8% compared to the same quarter last year. During the same period in the prior year, the firm posted $0.71 EPS. On average, analysts predict that HCP, Inc. will post $1.35 earnings per share for the current fiscal year.

The business also recently declared a quarterly dividend, which was paid on Tuesday, August 22nd. Investors of record on Monday, August 7th were given a $0.37 dividend. This represents a $1.48 dividend on an annualized basis and a yield of 4.90%. The ex-dividend date was Thursday, August 3rd. HCP’s payout ratio is currently 102.07%.

Several analysts have commented on the stock. UBS AG upgraded shares of HCP from an “underperform” rating to an “outperform” rating in a report on Wednesday, June 14th. Goldman Sachs Group, Inc. (The) downgraded shares of HCP from a “buy” rating to a “neutral” rating and dropped their target price for the stock from $35.00 to $32.00 in a report on Monday, July 24th. Stifel Nicolaus restated a “hold” rating and set a $31.00 target price on shares of HCP in a report on Friday, July 14th. BidaskClub upgraded shares of HCP from a “hold” rating to a “buy” rating in a report on Wednesday, June 21st. Finally, Mizuho restated a “neutral” rating on shares of HCP in a report on Wednesday, June 28th. Three research analysts have rated the stock with a sell rating, thirteen have given a hold rating and three have given a buy rating to the company’s stock. The company has a consensus rating of “Hold” and an average target price of $32.84.

In related news, insider Thomas Klaritch sold 2,651 shares of the stock in a transaction on Tuesday, June 13th. The stock was sold at an average price of $31.53, for a total value of $83,586.03. Following the completion of the sale, the insider now directly owns 176,830 shares of the company’s stock, valued at approximately $5,575,449.90. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Corporate insiders own 0.22% of the company’s stock.

About HCP

HCP, Inc is a self-administered real estate investment trust. The Company invests in real estate serving the healthcare industry in the United States. The Company’s segments include senior housing triple-net (SH NNN), senior housing operating portfolio (SHOP), life science and medical office. Its senior housing facilities include independent living facilities, assisted living facilities, memory care facilities, care homes, and continuing care retirement communities.

Want to see what other hedge funds are holding HCP? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCP, Inc. (NYSE:HCP).

Institutional Ownership by Quarter for HCP (NYSE:HCP)

Receive News & Ratings for HCP Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCP Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply